The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer.

dc.contributor.author Kelminski, Ann
dc.date.accessioned 2016-10-25T23:01:07Z
dc.date.available 2016-10-25T23:01:07Z
dc.date.issued 2002-09
dc.identifier.issn 0017-8594
dc.identifier.pubmed 12422387
dc.identifier.uri http://hdl.handle.net/10524/53680
dc.language.iso eng
dc.subject.mesh Antineoplastic Agents, Hormonal/therapeutic use
dc.subject.mesh Breast Neoplasms/prevention & control
dc.subject.mesh Eligibility Determination
dc.subject.mesh Female
dc.subject.mesh Hawaii/epidemiology
dc.subject.mesh Humans
dc.subject.mesh Patient Participation
dc.subject.mesh Raloxifene Hydrochloride/therapeutic use
dc.subject.mesh Randomized Controlled Trials as Topic
dc.subject.mesh Risk Factors
dc.subject.mesh Tamoxifen/therapeutic use
dc.title The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer.
dc.type Article
dc.type.dcmi Text
prism.number 9
prism.pagerange 209-10
prism.publicationname Hawaii Medical Journal
prism.volume 61
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
2002-09p209-210.pdf
Size:
244.54 KB
Format:
Adobe Portable Document Format
Description: